![]() Interface Biologics Interface Biologics is a developer of transformative biomedical polymer technology solutions that improve the safety and effectiveness of medical devices. | ![]() Regenicin Regenicin is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. | ||||
Founding Date | Founding Date 2015 | Founding Date 2001 | Founding Date 2010 | Founding Date 2010 | Founding Date 2011 |
Type | Type Private | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Bedford, GB HQ | Locations Toronto, CA HQ | Locations Little Falls, US HQ | Locations Rødovre, DK HQ | Locations Geleen, NL HQ |
Employees | Employees 9 | Employees 7 | Employees 3 | Employees 4 | Employees 6 |
Funding | |||||
Latest funding round | Latest funding round $ 6.4m (almost 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 2.2m (over 9 years ago) | Latest funding round $ 2.4m (over 8 years ago) |
Total funding raised | Total funding raised $ 8.9m | Total funding raised $ 32m | Total funding raised N/A | Total funding raised $ 2.2m | Total funding raised $ 2.4m |

Interface Biologics is a developer of transformative biomedical polymer technology solutions that improve the safety and effectiveness of medical devices.
View company
Regenicin is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs.
View companyBiomodics is a company providing services and technologies to the life science industry.
View companyTripleMed is a company developing solutions for the treatment of aortic aneurysms.
View company